-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Reiterates Outperform on Compass Pathways, Maintains $20 Price Target

Benzinga·07/07/2026 17:07:01
Listen to the news
Oppenheimer analyst Francois Brisebois reiterates Compass Pathways (NASDAQ:CMPS) with a Outperform and maintains $20 price target.